Marketing compliance software for pharmaceutical brands

Pharmaceutical promotion is among the most regulated marketing there is. In the United States, the FDA reviews promotional material through its Office of Prescription Drug Promotion. In Australia, therapeutic-goods advertising is regulated by the TGA under the Therapeutic Goods Act 1989 and the Therapeutic Goods Advertising Code.

Cohiva Campaign turns your internal review into a control the platform enforces. Go-live is rejected at the API with HTTP 422 until every checklist item passes, and the failed items are returned.

Proofing and approvals run together. Reviewers drop positional annotations on creative, compare versions side by side, and route work through ordered approval stages with a clear author and approver separation.

When the checklist passes, Campaign generates a timestamped compliance certificate and records the decision in an append-only audit, giving regulatory affairs a clean, exportable history.

For a pharmaceutical brand, the practical value is that promotional review stops depending on memory and email. A regulatory reviewer annotates the precise claim on the creative, the approval stages keep that reviewer separate from the person who produced the work, and the gate refuses to let a campaign go live until the configured checks pass. Because the annotated proof, the approval decisions, and the certificate sit together against the same campaign, regulatory affairs can produce a single ordered account of how a given claim was reviewed, which is far easier to stand behind than a scattered trail of file versions.

Start a free trial of Cohiva Campaign to put a non-bypassable go-live gate behind every launch.